Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 120 Unit, and 240 unit of botulinum toxin A
are effective in the treatment of migraine without aura prophylaxis.
Phase:
Phase 3
Details
Lead Sponsor:
Rajavithi Hospital
Collaborators:
Chiang Mai University Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA